System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Vahan Kepenekian is an expert in Surgery at Centre Hospitalier Lyon Sud (France). Vahan Kepenekian has authored 195 publications, the most recent in 2026, and is an investigator in 9 clinical trials, 5 of them ongoing. SLR score: 634 (community average: 125). How the SLR is computed.

LeadR Profile

Vahan Kepenekian Centre Hospitalier Lyon Sud France
634 ScienceLeadR Reputation 634

Unlock

Register Login
Network Map

Surgery

Subspecialties: Oncology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2013 - 2026
Source: PubMed

Claude Bernard University Lyon 1

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 195

Citations

Citations: 3 748 1st author: 21 Last author: 15 Unique author: 0

Main journals

Eur J Surg Oncol 37
Ann Surg Oncol 32
Br J Surg 7
Colorectal Dis 5
Int J Hyperthermia 5

Best Journals

J Clin Oncol 5
Ann Oncol 2
Lancet Oncol 2

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Comparison of surgical and oncological outcomes following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in upper and middle/lower rectal peritoneal metastases.
PMID 42648158 — cytoreduction surgical procedures, hyperthermia, induced, hyperthermic intraperitoneal chemotherapy, drug therapy, neoplasm metastasis, risk factors, chemotherapy		Surg Oncol20260
Editorial: Reading One Metastasis to Predict Another: Histological Growth Patterns in Colorectal Cancer.
PMID 42681167 — reading, growth, neoplasms, neoplasm metastasis, colorectal neoplasms		Ann Surg Oncol20260
Networking is Essential for the Proper Management of Rare Cancers: From Recognition to Implementation.
PMID 42390666 — neoplasms		Ann Surg Oncol20260
Molecular profiling and personalized medicine within EURACAN in the SPECTA Arcagen study in comparison to the France Genomic Medicine 2025 Plan in the AURAGEN platform in peritoneal mesotheliomas.
PMID 42150333 — blood, mesothelioma, neoplasms, precision medicine, therapeutics, tissues, genomic medicine		Transl Oncol20260
Thromboprophylaxis, pain and organization: How do expert centers manage PIPAC's perioperative care? An international survey.
PMID 42143535 — pain, perioperative care, biological monitoring, environmental monitoring, pressurized intraperitoneal aerosol chemotherapy		Eur J Surg Oncol20260

Clinical Studies 9

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 4
Phase 1/Phase 2 2
Phase 2 2
Phase 3 1

By status:

Recruiting 4
Completed 2
Not yet recruiting 1
Terminated 1
Unknown 1

By type:

Interventional 6
Observational 3

By Monocentric/Multicentric:

monocentric 4
multicentric2to4 1
multicentric5to9 1
multicentricup10 3

Main Topics

Cohort/Consortium Investigators 14

Ongoing Clinical Trials

5 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Systemic antitumor treatment with or without pressurized intraperitoneal aerosol chemotherapy (PIPAC) for colon peritoneal metastases a multicentre phase II randomized trial (PIPOX02)
2024-514560-10-00 — aerosols, neoplasms, colon, drug therapy, neoplasm metastasis, therapeutics, chemotherapy, pressurized intraperitoneal aerosol chemotherapy		Phase 2Recruiting2025
Blood Clearance Kinetics of the Nucleosome and CTCF in Peritoneal Metastasis Colorectal Cancer
NCT06929013 — cells, blood, blood specimen collection, neoplasms, nucleosomes, biomarkers, neoplasm metastasis, peritoneal neoplasms, colorectal neoplasms, men		N/ARecruiting2025
Systemic Antitumor Treatment with or Without Pressurized Intraperitoneal Aerosol Chemotherapy for Colon Peritoneal Metastases (PIPOX02)
NCT06681038 — surgical oncology, vascular endothelial growth factor a, progression-free survival, aerosols, neoplasms, colon, drug therapy, oxaliplatin, neoplasm metastasis, therapeutics, colorectal neoplasms, chemotherapy, pressurized intraperitoneal aerosol chemotherapy		Phase 2Not yet recruiting2025
Neoadjuvant Chemotherapy for Obstructive Colon cancER First Treated by cOlostomy
NCT06107920 — colostomy, neoplasms, colon, drug therapy, chemotherapy, adjuvant, neoadjuvant therapy, therapeutics, colectomy, colonic neoplasms, chemotherapy		Phase 3Recruiting2024
CIRculating CANcer MAster Protocol
NCT05089747 — cells, blood, blood specimen collection, micrornas, neoplasms, biopsy, cell-free nucleic acids, biomarkers, nucleic acids, diagnosis, therapeutics, circulating microrna, dna, liquid biopsy		N/ARecruiting2022

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS